WT1 and breast cancer: The results of our study indicated that after PS adjustment, WT1 methylation was associated with the risk of luminal A and luminal B subtypes of breast cancer with ORs of 2.62 and 3.23, and CA10 methylation was significantly associated with luminal B subtype of breast cancer with OR of 1.80.